Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
TRANSITION THERAPEUTICS INC.
T.TTH
Healthcare
Biotechnology
"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TTH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on Oct 15, 2015 9:56am
Dead or what?
Where is everybody? Is Shawshank still around?
(0)
•••
gmarc66
X
View Profile
View Bullboard History
Post by
gmarc66
on Jul 16, 2015 1:28pm
inching up today....
climbing off bottom on low vol...it could be a slow climb up...cheap shares could be golden one day...any decent news will also pop it of course...would be nice to see it over $4 again...and on its
...more
(14)
•••
eunice12
X
View Profile
View Bullboard History
Comment by
eunice12
on Jun 27, 2015 1:55am
RE:RE:RE:RE:RE:60 million cash and a promising lead drug
You are fixated on repetitive misspelling that word - do you have a point? They have an MSc, provide in depth analysis and spoke to clinicians in the field - which is a step up from a 2 sentence bb
...more
(0)
•••
testfreak
X
View Profile
View Bullboard History
Comment by
testfreak
on Jun 27, 2015 1:39am
RE:RE:RE:RE:RE:60 million cash and a promising lead drug
also noting several ANAL-ists have a buy rating on TTH and a hold. NO sells.... but that means nothing the ANAL-IST
(0)
•••
testfreak
X
View Profile
View Bullboard History
Comment by
testfreak
on Jun 27, 2015 1:38am
RE:RE:RE:RE:60 million cash and a promising lead drug
nothing but nonesense. dont bother responding. i bet this well over $3.50 by mid end of july. stock is dirt cheap at this price. several projects going, and if u beleive what ever ANAL-ist well thats
...more
(14)
•••
eunice12
X
View Profile
View Bullboard History
Comment by
eunice12
on Jun 27, 2015 1:28am
RE:RE:RE:60 million cash and a promising lead drug
Canaccord below assumes only 30% chance of success. Do you realize what happens to your money if the 70% occurs, and how much bigger 70 is than 30? Insane risk - consider how many slam dunk medical
...more
(0)
•••
testfreak
X
View Profile
View Bullboard History
Post by
testfreak
on Jun 27, 2015 12:39am
interesting times ahead for T.TTH. uptrend will start
Lots going on. Several trials underway Transition Therapeutics licenses androgen receptor modulator from LillyMay. 6, 2015 10:18 AM• SA Editor Douglas W. House Transition
...more
(0)
•••
testfreak
X
View Profile
View Bullboard History
Comment by
testfreak
on Jun 26, 2015 11:03pm
RE:RE:60 million cash and a promising lead drug
eunice12 wrote: Canaccord target just $3.25. You guys are dreaming this will bounce back or that volume means anything. Traders don't work at TTH. ELND005 is toast per Canaccord report I read, and
...more
(14)
•••
eunice12
X
View Profile
View Bullboard History
Comment by
eunice12
on Jun 26, 2015 10:43pm
RE:Insane cheap here
You don't seem to understand the meaning of the word "if" even though you use it.
(0)
•••
testfreak
X
View Profile
View Bullboard History
Post by
testfreak
on Jun 26, 2015 9:37pm
Insane cheap here
Lilly has assumed all development and commercialization rights to type 2 diabetes drug candidate TT401. If TT-401 is successfully commercialized, Transition will be eligible to receive approximately
...more
(14)
•••
eunice12
X
View Profile
View Bullboard History
Comment by
eunice12
on Jun 26, 2015 1:16pm
RE:60 million cash and a promising lead drug
Canaccord target just $3.25. You guys are dreaming this will bounce back or that volume means anything. Traders don't work at TTH. ELND005 is toast per Canaccord report I read, and
...more
(4)
•••
uptick144
X
View Profile
View Bullboard History
Post by
uptick144
on Jun 25, 2015 10:28am
60 million cash and a promising lead drug
This will bounce to five at a minimum! "It has barely even traded any volume. LOL..no brainer here
(0)
•••
krbcan
X
View Profile
View Bullboard History
Comment by
krbcan
on Jun 24, 2015 11:08pm
RE:RE:Fortunes Decimated
4.25 million stock traded on Nasdaq today. After hours, it climbed by 10 cents, so hopefully it will claw its way back over time, although it will take good news of some type to really help it
...more
(25)
•••
smush74
X
View Profile
View Bullboard History
Comment by
smush74
on Jun 24, 2015 8:25pm
RE:Fortunes Decimated
it is always a risk taking nothing to become somethng. It is a loss but not then end of the world for TTH, they are not a one trick pony, they still have money and other trials going on. Bios' are
...more
(0)
•••
stockseer
X
View Profile
View Bullboard History
Post by
stockseer
on Jun 24, 2015 3:21pm
Fortunes Decimated
there is so much risk in investing in such stocks because if a result of a promising drug is negative - it can cause such a sudden loss
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income